-
1
-
-
34548047185
-
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A meta-analysis
-
Tang B, Eslick G, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007; 370: 657-666.
-
(2007)
Lancet
, vol.370
, pp. 657-666
-
-
Tang, B.1
Eslick, G.2
Nowson, C.3
-
2
-
-
39149101470
-
Vascular events in healthy older women receiving calcium supplementation: Randomised controlled trial
-
Bolland M, Barber P, Doughty R, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008; 336: 262-266.
-
(2008)
BMJ
, vol.336
, pp. 262-266
-
-
Bolland, M.1
Barber, P.2
Doughty, R.3
-
3
-
-
33747892255
-
Randomized controlled trial of calcium in healthy older women
-
Reid IR, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med 2006; 119: 777-785.
-
(2006)
Am J Med
, vol.119
, pp. 777-785
-
-
Reid, I.R.1
Mason, B.2
Horne, A.3
-
4
-
-
33847110738
-
Calcium/vitamin D supplementation and cardiovascular events
-
Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007; 115: 846-854.
-
(2007)
Circulation
, vol.115
, pp. 846-854
-
-
Hsia, J.1
Heiss, G.2
Ren, H.3
-
5
-
-
0026613738
-
Vitamin D3 and calcium to prevent hip fractures in the elderly women
-
Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327: 1637-1642.
-
(1992)
N Engl J Med
, vol.327
, pp. 1637-1642
-
-
Chapuy, M.C.1
Arlot, M.E.2
Duboeuf, F.3
-
6
-
-
0036123720
-
Combined calcium and vitamin D3 supplementation in elderly women: Confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study
-
Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002; 13: 257-264.
-
(2002)
Osteoporos Int
, vol.13
, pp. 257-264
-
-
Chapuy, M.C.1
Pamphile, R.2
Paris, E.3
-
7
-
-
1642555543
-
A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NoNOF) Study
-
Harwood R, Sahota O, Gaynor K, et al. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: the Nottingham Neck of Femur (NoNOF) Study. Age Ageing 2004; 33: 45-31.
-
(2004)
Age Ageing
, vol.33
, pp. 45-31
-
-
Harwood, R.1
Sahota, O.2
Gaynor, K.3
-
8
-
-
18044388395
-
Randomised controlled trial of supplementation with calcium and cholecalciferol (vitamin D3) for prevention of fractures in primary care
-
Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of supplementation with calcium and cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005; 330: 1003-1006.
-
(2005)
BMJ
, vol.330
, pp. 1003-1006
-
-
Porthouse, J.1
Cockayne, S.2
King, C.3
-
9
-
-
18744369929
-
RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): A randomised placebo-controlled trial
-
Grant AM, Avenell A, Campbell MK, et al; RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005; 365: 1621-1628.
-
(2005)
Lancet
, vol.365
, pp. 1621-1628
-
-
Grant, A.M.1
Avenell, A.2
Campbell, M.K.3
-
10
-
-
0033338731
-
Pharmacokinetics of calcium absorption from two commercial calcium supplements
-
Heller HJ, Stewart A, Haynes S, Pak CYC. Pharmacokinetics of calcium absorption from two commercial calcium supplements. J Clin Pharmacol 1999; 39: 1151-1154.
-
(1999)
J Clin Pharmacol
, vol.39
, pp. 1151-1154
-
-
Heller, H.J.1
Stewart, A.2
Haynes, S.3
Pak, C.Y.C.4
|